Charming Medical (MCTA) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
21 Jan, 2026Offering summary
IPO of Class A ordinary shares on Nasdaq under symbol MCTA, offering 1,600,000 shares at $4–$6 per share, targeting $8 million in proceeds.
Post-offering, 14,938,000 Class A and 2,000,000 Class B shares will be outstanding if no over-allotment is exercised.
Proceeds allocated: 40% for business/geographic expansion, 30% for strategic investments/acquisitions, 10% for R&D, 20% for working capital.
Underwriter is Cathay Securities, Inc.
Company profile and services
Integrates Traditional Chinese Medicine (TCM) with modern technology to offer wellness and beauty services, primarily for women, with tailored therapies for men.
Operates four wellness centers in Hong Kong and launched a franchise model in March 2025.
Services include TCM-inspired therapies, beauty and postpartum care, hair restoration, consultancy, and training programs.
Product lines feature supplements, uterine care patches, and specialized washes.
Corporate structure and history
Holding company structure with subsidiaries in Hong Kong, including Pilate International, My Beauty Technology, Dream International Trading, and Choliya Limited.
Charming Medical Limited became the holding company in November 2024.
Founder Kit Wong holds majority of Class A and all Class B shares pre- and post-IPO.
Latest events from Charming Medical
- Hong Kong TCM wellness firm targets $6.6M Nasdaq IPO for expansion amid growth and regulatory risks.MCTA
Registration Filing21 Jan 2026 - IPO targets $6.6M for TCM wellness expansion, but faces going concern and regulatory risks.MCTA
Registration Filing21 Jan 2026 - Profitable TCM wellness firm seeks $6.6M IPO for expansion, but faces liquidity and regulatory risks.MCTA
Registration Filing21 Jan 2026 - Public offering follows share split, capital restructuring, and new governance policies.MCTA
Registration Filing21 Jan 2026